Use

The Congenital Adrenal Hyperplasia (CAH) Panel is intended for individuals or fetuses with a clinical or suspected diagnosis of congenital adrenal hyperplasia, individuals with abnormal newborn screening results suggesting 21-hydroxylase deficiency, and reproductive partners of individuals with a known pathogenic variant in the related genes of this panel. The test aids in identifying pathogenic variants in the genes associated with CAH, facilitating diagnosis and carrier status determination.